Investor · Waltham, MA

Marc Cohen

Open Marc in the network graph →

Filings

14

SEC Form D

Connections

53

co-filers

Capital

$28.7M

across filings

Active

Jan 2019

to Mar 2025

Most-connected co-filers (53)

Rita J. Sallis · NEW YORK, NY10 shared Jonathan Medearis · Glendale, CO10 shared Michael A. Nicklas · Grand Cayman, Cayman Islands7 shared Christopher J. Ward · NEW YORK, NY7 shared Sheeraz Haji · SAN FRANCISCO, CA7 shared Raj Gollamudi · Palo Alto, CA6 shared Anne J. Cleary · NEW YORK, NY6 shared John Rocha · Waltham, MA4 shared Daguang L. Wang · Waltham, MA4 shared Simon Jones · Waltham, MA3 shared Vumindaba J. Dube · NEW YORK, NY3 shared David Wilson · BRAINTREE, MA3 shared Chieh-Yu Lin · SAN DIEGO, CA2 shared Jeffrey C. Lightcap · Lewisville, TX2 shared Michelle E. Bauerly Kopel · St Cloud, MN2 shared Shixiang L. Yan · Waltham, MA2 shared Michael L. Huang · Waltham, MA2 shared Peter Jubber · Boston, MA2 shared Gregory A. Schumacher · St Cloud, MN2 shared Jeffrey A. Cella · Bethlehem, PA2 shared Patrick K. Edeburn · St Cloud, MN2 shared Tejas Gosai · Bethlehem, PA2 shared Timothy J. Zak · Pittsburgh, PA2 shared James J. Liken · Pittsburgh, PA2 shared

Recent filings (14)

IIF Cayman 1 Ltd.Mar 2025 · 5 co-filers IIF HEDGED LPMar 2025 · 8 co-filers IIF CAYMAN 1 HEDGED LTD.Mar 2025 · 5 co-filers IIF Erisa LPMar 2025 · 8 co-filers IIF Dutch 1 Cayman L.P.Mar 2025 · 5 co-filers IIF ERISA HEDGED LPMar 2025 · 8 co-filers IIF TAX-EXEMPT HEDGED LPMar 2025 · 8 co-filers IIF Tax-Exempt LPMar 2025 · 8 co-filers IIF LPMar 2025 · 8 co-filers Regenacy Pharmaceuticals, Inc.Feb 2022 · 20 co-filers$10.0M Regenacy Pharmaceuticals, Inc.Apr 2020 · 20 co-filers$40.7M Granite Equity Associates LLCJan 2019 · 11 co-filers$50.0M IIF ERISA HEDGED LPJan 2019 · 8 co-filers Granite Equity LLCJan 2019 · 37 co-filers$50.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Marc in the interactive graph →